相关实验视频
Updated: Jan 10, 2026

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
2.2K
文本由SFAR临床参考委员会于2024年4月30日,SFAR董事会于2024年5月27日,SFPC董事会于2024年9月12日批准
Alexandre Theissen1, Remy Collomp2, Charles-Hervé Vacheron3
1Anesthésie - Réanimation Chirurgicale Clinique Saint François, Pierre-Bénite, France.
Anaesthesia, critical care & pain medicine
|November 28, 2025
概括
法国专家制定了29条实践指南,以防止麻醉和重症监护中的药物错误,并达成了强有力的共识. 这些建议旨在提高重症监护机构的患者安全.
科学领域:
- 麻醉学 麻醉学
- 临床药房 临床药房
- 患者安全 患者安全
背景情况:
- 药物错误在麻醉和重症监护中构成重大风险.
- 专业协会认识到需要标准化指导方针来缓解这些错误.
研究的目的:
- 制定基于证据的专业实践指南,以防止药物错误.
- 为麻醉和重症监护的医疗保健专业人员提供可行的建议.
主要方法:
- 一个由SFAR和SFPC的19名专家组成的小组召开会议.
- 用GRADE方法来评估证据的质量.
- 在四个关键领域制定了建议:工作环境,人为因素,风险管理和药物短缺.
主要成果:
- 通过专家的共识,制定了29个不同的建议.
- 评估,发展和评价 (GRADE) 方法指导了证据评估.
- 在所有提出的建议上达成了强有力的共识.
结论:
- 专家们在提出的建议上达到了强烈的共识.
- 这些指导方针旨在加强在重症监护环境中预防药物错误.
相关概念视频
SBAR II: Application of SBAR
5.6K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
5.6K
Standards of Care II
1.0K
Nurses bear specific legal responsibilities under several federal statutes, including:
1.0K
Standards of Care I
1.0K
Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
1.0K
Clinically Relevant Drug Product Specifications: Methods of Establishment
186
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
186
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K

